Vitamin D3 Metabolites Demonstrate Prognostic Value in EGFR-Mutant Lung Adenocarcinoma and Can be Deployed to Oppose Acquired Therapeutic Resistance

EGFR tyrosine kinase inhibitors (EGFR TKIs) are the standard of care treatment for patients with EGFR-mutant lung adenocarcinoma (LUAD). Although initially effective, EGFR TKIs are not curative. Disease inevitably relapses due to acquired drug resistance. We hypothesized that vitamin D metabolites c...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaurova, Tatiana, Dy, Grace K, Battaglia, Sebastiano, Hutson, Alan, Zhang, Letian, Zhang, Yunkai, Lovly, Christine M, Seshadri, Mukund, Goodrich, David W, Johnson, Candace S, Hershberger, Pamela A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140110/
https://www.ncbi.nlm.nih.gov/pubmed/32183160
http://dx.doi.org/10.3390/cancers12030675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140110/
https://www.ncbi.nlm.nih.gov/pubmed/32183160
http://dx.doi.org/10.3390/cancers12030675

Ejemplares similares